Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

Patients with CSU have a higher burden than patients with CIndU, including on quality of life, economic effect, and knowledge about treatment.

Thus, health insurance effectively mitigates the impact of diseases on individual income, reduces the likelihood of individuals falling into poverty, prevents recurring poverty, and consolidates the ...

Chronic diseases, a global public health challenge, necessitate the deployment of cutting-edge predictive models for early diagnosis and personalized interventions. This study presents an advanced ...

Post-COVID data show that circulatory claims have increased by nearly 60%, while neoplasms remain the leading source of ...

Venous disease is a term that broadly covers both venous thromboembolic disease and chronic venous disease. The basic pathophysiology of venous thromboembolism and chronic venous disease differ as ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Patients with chronic respiratory failure who meet usage criteria will have more access to respiratory assist devices.

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...

A recent White House executive order could make it harder for millions of Americans to access their lifesaving medications.

Publications 2025 Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses Around 10-20% of people who contract Lyme disease, the most common tickborne disease in the U.S.

A quarter of people seeking care for symptoms of chronic respiratory diseases in Kenya may incur 'catastrophic' health costs, new research published in The Lancet Global Health has found.